c-LEcta Management

About c-LEcta Exit

c-LEcta is a leading biotechnology company located in Leipzig, Germany. The company has established itself as a leading player in the realisation of high-value biotechnology products for regulated markets, either as in-house development or in close cooperation with the industry. c-LEcta innovation capability delivers cost-efficient and sustainable production processes, creating growth opportunities across existing and new markets.

Press releases

15. February 2022

Very Successful Exit for High-Tech Gründerfonds – Kerry acquires c-LEcta

This strategically compelling combination will accelerate Kerry’s innovation capabilities in enzyme engineering, fermentation and bio-process developmentThe global presence of Kerry Group plc in the food and pharmaceutical sectors givesc-LEcta access to additional marketsHigh-Tech Gründerfonds was the first seed investor of c-LEcta High-Tech Gründerfonds (“HTGF”) sells its shares in c-LEcta after accompanying the company for 16 years. Kerry Group plc (“Kerry”), the global
23. August 2018

c-LEcta lays foundation for further growth and closes financing round

Closing of financing round with new investors Capricorn and bm|t brings growth capital and valuable access to international network Growth financing to take c-LEcta to a new level by upscaling food ingredients manufacturing to commercial production in a multi-billion-euro market New CFO Thomas Pfaadt to manage and support growth   c-LEcta, a world-leading biotechnology company focused on enzyme engineering and applications in regulated markets like food and p

Info & Contact

Dr. Marc Struhalla
Thomas Pfaadt


Perlickstraße 5
04103 Leipzig

In portfolio

19. Jan 2006 – 15. Feb 2022

Marco Winzer